Insmed (INSM) Net Margin Growth (1y) (2011 - 2026)
Insmed (INSM) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,491.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 447.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Insmed | 23.26 Bn | 22.03 Bn | 258.54 Mn | 22,296.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22,296.00 |
| Dec 31, 2025 | 10,103.00 |
| Sep 30, 2025 | -2,391.00 |
| Jun 30, 2025 | 3,327.00 |
| Mar 31, 2025 | -6,835.00 |
| Dec 31, 2024 | -322.00 |
| Sep 30, 2024 | -3,505.00 |
| Jun 30, 2024 | -1,576.00 |
| Mar 31, 2024 | 3,692.00 |
| Dec 31, 2023 | 4,771.00 |
| Sep 30, 2023 | -737.00 |
| Jun 30, 2023 | -17,034.00 |
| Mar 31, 2023 | -6,681.00 |
| Dec 31, 2022 | -6,872.00 |
| Sep 30, 2022 | 4,743.00 |
| Jun 30, 2022 | 11,196.00 |
| Mar 31, 2022 | 4,971.00 |
| Dec 31, 2021 | 4,550.00 |
| Sep 30, 2021 | -9,520.00 |
| Jun 30, 2021 | -11,305.00 |